BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu D, Van Belleghem JD, de Vries CR, Burgener E, Chen Q, Manasherob R, Aronson JR, Amanatullah DF, Tamma PD, Suh GA. The Safety and Toxicity of Phage Therapy: A Review of Animal and Clinical Studies. Viruses 2021;13:1268. [PMID: 34209836 DOI: 10.3390/v13071268] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Huang Y, Wang W, Zhang Z, Gu Y, Huang A, Wang J, Hao H. Phage Products for Fighting Antimicrobial Resistance. Microorganisms 2022;10:1324. [DOI: 10.3390/microorganisms10071324] [Reference Citation Analysis]
2 Wang X, Xie Z, Zhao J, Zhu Z, Yang C, Liu Y. Prospects of Inhaled Phage Therapy for Combatting Pulmonary Infections. Front Cell Infect Microbiol 2021;11:758392. [PMID: 34938668 DOI: 10.3389/fcimb.2021.758392] [Reference Citation Analysis]
3 Iszatt JJ, Larcombe AN, Chan HK, Stick SM, Garratt LW, Kicic A. Phage Therapy for Multi-Drug Resistant Respiratory Tract Infections. Viruses 2021;13:1809. [PMID: 34578390 DOI: 10.3390/v13091809] [Reference Citation Analysis]
4 Rodriguez JM, Woodworth BA, Horne B, Fackler J, Brownstein MJ. Case Report: successful use of phage therapy in refractory MRSA chronic rhinosinusitis. Int J Infect Dis 2022;121:14-6. [PMID: 35472526 DOI: 10.1016/j.ijid.2022.04.049] [Reference Citation Analysis]
5 Michán C, Michán-Doña A. Viruses: Friends or foes. Microb Biotechnol 2021. [PMID: 34634193 DOI: 10.1111/1751-7915.13948] [Reference Citation Analysis]
6 Au TY, Assavarittirong C. Combating antimicrobial resistance: an evidence-based overview of bacteriophage therapy. Postgrad Med J 2022:postgradmedj-2022-141546. [PMID: 35379752 DOI: 10.1136/postgradmedj-2022-141546] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Racenis K, Rezevska D, Madelane M, Lavrinovics E, Djebara S, Petersons A, Kroica J. Use of Phage Cocktail BFC 1.10 in Combination With Ceftazidime-Avibactam in the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Femur Osteomyelitis-A Case Report. Front Med (Lausanne) 2022;9:851310. [PMID: 35547216 DOI: 10.3389/fmed.2022.851310] [Reference Citation Analysis]
8 Yan R, Lu Y, Wu X, Yu P, Lan P, Wu X, Jiang Y, Li Q, Pi X, Liu W, Zhou J, Yu Y. Anticolonization of Carbapenem-Resistant Klebsiella pneumoniae by Lactobacillus plantarum LP1812 Through Accumulated Acetic Acid in Mice Intestinal. Front Cell Infect Microbiol 2021;11:804253. [PMID: 34976873 DOI: 10.3389/fcimb.2021.804253] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 DePalma BJ, Nandi S, Chaudhry W, Lee M, Johnson AJ, Doub JB. Assessment of Staphylococcal Clinical Isolates from Periprosthetic Joint Infections for Potential Bacteriophage Therapy. J Bone Joint Surg Am 2022. [PMID: 35167506 DOI: 10.2106/JBJS.21.00958] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Kowalski J, Górska R, Cieślik M, Górski A, Jończyk-matysiak E. What Are the Potential Benefits of Using Bacteriophages in Periodontal Therapy? Antibiotics 2022;11:446. [DOI: 10.3390/antibiotics11040446] [Reference Citation Analysis]
11 Suh GA, Lodise TP, Tamma PD, Knisely JM, Alexander J, Aslam S, Barton KD, Bizzell E, Totten KMC, Campbell JL, Chan BK, Cunningham SA, Goodman KE, Greenwood-Quaintance KE, Harris AD, Hesse S, Maresso A, Nussenblatt V, Pride D, Rybak MJ, Sund Z, van Duin D, Van Tyne D, Patel R; Antibacterial Resistance Leadership Group. Considerations for the Use of Phage Therapy in Clinical Practice. Antimicrob Agents Chemother 2022;66:e0207121. [PMID: 35041506 DOI: 10.1128/AAC.02071-21] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 12.0] [Reference Citation Analysis]
12 Khan A, Rao TS, Joshi HM. Phage therapy in the Covid-19 era: Advantages over antibiotics. Curr Res Microb Sci 2022;:100115. [PMID: 35187507 DOI: 10.1016/j.crmicr.2022.100115] [Reference Citation Analysis]
13 Xu Z, Shao S, Ding Z, Zhang Y, Wang Q, Liu X, Liu Q. Therapeutic Efficacies of Two Newly Isolated Edwardsiella Phages Against Edwardsiella piscicida Infection. Microbiological Research 2022. [DOI: 10.1016/j.micres.2022.127043] [Reference Citation Analysis]
14 Vagima Y, Gur D, Aftalion M, Moses S, Levy Y, Makovitzki A, Holtzman T, Oren Z, Segula Y, Fatelevich E, Tidhar A, Zauberman A, Rotem S, Mamroud E, Steinberger-levy I. Phage Therapy Potentiates Second-Line Antibiotic Treatment against Pneumonic Plague. Viruses 2022;14:688. [DOI: 10.3390/v14040688] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
15 Chen Q, Dharmaraj T, Cai PC, Burgener EB, Haddock NL, Spakowitz AJ, Bollyky PL. Bacteriophage and Bacterial Susceptibility, Resistance, and Tolerance to Antibiotics. Pharmaceutics 2022;14:1425. [DOI: 10.3390/pharmaceutics14071425] [Reference Citation Analysis]
16 Wang Y, Subedi D, Li J, Wu J, Ren J, Xue F, Dai J, Barr JJ, Tang F. Phage Cocktail Targeting STEC O157:H7 Has Comparable Efficacy and Superior Recovery Compared with Enrofloxacin in an Enteric Murine Model. Microbiol Spectr 2022;:e0023222. [PMID: 35536028 DOI: 10.1128/spectrum.00232-22] [Reference Citation Analysis]
17 Meile S, Du J, Dunne M, Kilcher S, Loessner MJ. Engineering therapeutic phages for enhanced antibacterial efficacy. Curr Opin Virol 2021;52:182-91. [PMID: 34952266 DOI: 10.1016/j.coviro.2021.12.003] [Cited by in Crossref: 5] [Article Influence: 5.0] [Reference Citation Analysis]
18 Wu N, Chen LK, Zhu T. Phage therapy for secondary bacterial infections with COVID-19. Curr Opin Virol 2021;52:9-14. [PMID: 34800893 DOI: 10.1016/j.coviro.2021.11.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
19 Veeranarayanan S, Azam AH, Kiga K, Watanabe S, Cui L. Bacteriophages as Solid Tumor Theragnostic Agents. Int J Mol Sci 2021;23:402. [PMID: 35008840 DOI: 10.3390/ijms23010402] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Lood C, Haas PJ, van Noort V, Lavigne R. Shopping for phages? Unpacking design rules for therapeutic phage cocktails. Curr Opin Virol 2021;52:236-43. [PMID: 34971929 DOI: 10.1016/j.coviro.2021.12.011] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Mutalik VK, Arkin AP. A Phage Foundry Framework to Systematically Develop Viral Countermeasures to Combat Antibiotic-Resistant Bacterial Pathogens. iScience 2022;25:104121. [DOI: 10.1016/j.isci.2022.104121] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]